Gutenberg Open Science: Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy : results from the thrombEVAL study

Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-6363

Full metadata record

DC Field	Value	Language
dc.contributor.author	Eggebrecht, Lisa	-
dc.contributor.author	Ludolph, Paul	-
dc.contributor.author	Göbel, Sebastian	-
dc.contributor.author	Panova-Noeva, Marina	-
dc.contributor.author	Arnold, Natalie	-
dc.contributor.author	Nagler, Markus	-
dc.contributor.author	Bickel, Christoph	-
dc.contributor.author	Lauterbach, Michael	-
dc.contributor.author	Hardt, Roland	-
dc.contributor.author	ten Cate, Hugo	-
dc.contributor.author	Lackner, Karl J.	-
dc.contributor.author	Espinola-Klein, Christine	-
dc.contributor.author	Münzel, Thomas	-
dc.contributor.author	Prochaska, Jürgen H.	-
dc.contributor.author	Wild, Philipp S.	-
dc.date.accessioned	2021-09-24T08:04:59Z	-
dc.date.available	2021-09-24T08:04:59Z	-
dc.date.issued	2021	-
dc.identifier.uri	https://openscience.ub.uni-mainz.de/handle/20.500.12030/6373	-
dc.description.abstract	To evaluate the cost-saving of a specialized, eHealth-based management service (CS) in comparison to regular medical care (RMC) for the management of patients receiving oral anticoagulation (OAC) therapy. Costs of hospitalization were derived via diagnosis-related groups which comprise diagnoses (ICD-10) and operation and procedure classification system (OPS), which resulted in OAC-related (i.e. bleeding/ thromboembolic events) and non-OAC-related costs for both cohorts. Cost for anticoagulation management comprised INR-testing, personnel, and technical support. In total, 705 patients were managed by CS and 1490 patients received RMC. The number of hospital stays was significantly lower in the CS cohort compared to RMC (CS: 23.4/100 py; RMC: 68.7/100 py); with the most pronounced difference in OAC-related admissions (CS: 2.8/100 py; RMC: 13.3/100 py). Total costs for anticoagulation management amounted to 101 EUR/py in RMC and 311 EUR/py in CS, whereas hospitalization costs were 3261 [IQR 2857–3689] EUR/py in RMC and 683 [504–874] EUR/py in CS. This resulted in an overall cost saving 2368 EUR/py favoring the CS. The lower frequency of adverse events in anticoagulated patients managed by the telemedicine-based CS compared to RMC translated into a substantial cost-saving, despite higher costs for the specialized management of patients.	en_GB
dc.language.iso	eng	de
dc.rights	CC BY	*
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/	*
dc.subject.ddc	610 Medizin	de_DE
dc.subject.ddc	610 Medical sciences	en_GB
dc.title	Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy : results from the thrombEVAL study	en_GB
dc.type	Zeitschriftenaufsatz	de
dc.identifier.doi	http://doi.org/10.25358/openscience-6363	-
jgu.type.dinitype	article	en_GB
jgu.type.version	Published version	de
jgu.type.resource	Text	de
jgu.organisation.department	FB 04 Medizin	de
jgu.organisation.number	2700	-
jgu.organisation.name	Johannes Gutenberg-Universität Mainz	-
jgu.rights.accessrights	openAccess	-
jgu.journal.title	Scientific reports	de
jgu.journal.volume	11	de
jgu.pages.alternative	2577	de
jgu.publisher.year	2021	-
jgu.publisher.name	Macmillan Publishers Limited, part of Springer Nature	de
jgu.publisher.place	London	de
jgu.publisher.uri	https://doi.org/10.1038/s41598-021-82076-9	de
jgu.publisher.issn	2045-2322	de
jgu.organisation.place	Mainz	-
jgu.subject.ddccode	610	de
jgu.publisher.doi	10.1038/s41598-021-82076-9
jgu.organisation.ror	https://ror.org/023b0x485
Appears in collections:	JGU-Publikationen

Files in This Item:

	File	Description	Size	Format
	eggebrecht_lisa-cost_saving_an-20210922194241777.pdf		1.29 MB	Adobe PDF	View/Open

Show simple item record